Nuvectis Pharma Inc (NVCT) — Financial Flexibility Index
Nuvectis Pharma Inc (NVCT) has a Financial Flexibility Index of -0.39x as of September 2025. Free cash flow of $-4.49 Million (operating CF $-4.49 Million minus capex $0.00) represents 0% of total liabilities ($11.58 Million). Also explore how fast is Nuvectis Pharma Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nuvectis Pharma Inc Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for Nuvectis Pharma Inc across 5 annual periods. See Nuvectis Pharma Inc balance sheet independence to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Nuvectis Pharma Inc (2020–2024)
Year-by-year free cash flow to debt coverage for Nuvectis Pharma Inc. For the full company profile including market capitalisation, see NVCT company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.38x | $-12.25 Million | $-12.25 Million | $8.89 Million | ▲ +39.7% |
| 2023 | -2.28x | $-15.95 Million | $-15.95 Million | $6.98 Million | ▼ -4.2% |
| 2022 | -2.19x | $-13.56 Million | $-13.56 Million | $6.19 Million | ▼ -307.4% |
| 2021 | -0.54x | $-9.50 Million | $-9.50 Million | $17.66 Million | ▼ -122.4% |
| 2020 | 2.40x | $24.00K | $24.00K | $10.00K | — |